Discounting for cost benefit analysis involving private investment, but public benefit
13 January 2014
Body
Joint Regulators Group (JRG) statement on cost benefit analysis methodology JRG has published a statement on the methodology used for discounting for cost-benefit analyses (CBAs). These analyses may be used by regulators when considering measures that generate consumer or wider public benefits, while requiring regulated firms to incur some costs. CBAs enable regulators to estimate the value of the